BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 18771914)

  • 1. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.
    Schlemmer M; Reichardt P; Verweij J; Hartmann JT; Judson I; Thyss A; Hogendoorn PC; Marreaud S; Van Glabbeke M; Blay JY
    Eur J Cancer; 2008 Nov; 44(16):2433-6. PubMed ID: 18771914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
    Fata F; O'Reilly E; Ilson D; Pfister D; Leffel D; Kelsen DP; Schwartz GK; Casper ES
    Cancer; 1999 Nov; 86(10):2034-7. PubMed ID: 10570428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
    Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
    J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma.
    Skubitz KM; Haddad PA
    Cancer; 2005 Jul; 104(2):361-6. PubMed ID: 15948172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Reichardt P; Nielsen OS; Bauer S; Hartmann JT; Schöffski P; Christensen TB; Pink D; Daugaard S; Marreaud S; Van Glabbeke M; Blay JY;
    Eur J Cancer; 2007 Apr; 43(6):1017-22. PubMed ID: 17336054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
    Fanburg-Smith JC; Furlong MA; Childers EL
    Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin, cisplatin, ifosfamide and paclitaxel combination as front-line chemotherapy for locally advanced and metastatic angiosarcoma. Analysis of three case reports and review of the literature.
    Asmane I; Litique V; Heymann S; Marcellin L; Métivier AC; Duclos B; Bergerat JP; Kurtz JE
    Anticancer Res; 2008; 28(5B):3041-5. PubMed ID: 19031953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
    Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM
    J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of paclitaxel in the treatment of recurrent or metastatic soft tissue sarcomas or bone sarcomas.
    Gian VG; Johnson TJ; Marsh RW; Schuhmacher C; Lynch JW
    J Exp Ther Oncol; 1996 May; 1(3):186-90. PubMed ID: 9414403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic.
    Nascimento AF; Raut CP; Fletcher CD
    Am J Surg Pathol; 2008 Dec; 32(12):1896-904. PubMed ID: 18813119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of cutaneous angiosarcoma of the face and scalp and treatment with placitaxel.
    Pestoni C; Paredes-Suarez C; Peteiro C; Toribio J
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):357-9. PubMed ID: 15857466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Leahy M; Ray-Coquard I; Verweij J; Le Cesne A; Duffaud F; Hogendoorn PC; Fowst C; de Balincourt C; di Paola ED; van Glabbeke M; Judson I; Blay JY;
    Eur J Cancer; 2007 Jan; 43(2):308-15. PubMed ID: 17095209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and outcome of 82 patients with angiosarcoma.
    Abraham JA; Hornicek FJ; Kaufman AM; Harmon DC; Springfield DS; Raskin KA; Mankin HJ; Kirsch DG; Rosenberg AE; Nielsen GP; Desphpande V; Suit HD; DeLaney TF; Yoon SS
    Ann Surg Oncol; 2007 Jun; 14(6):1953-67. PubMed ID: 17356953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
    Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
    Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.
    Italiano A; Cioffi A; Penel N; Levra MG; Delcambre C; Kalbacher E; Chevreau C; Bertucci F; Isambert N; Blay JY; Bui B; Antonescu C; D'Adamo DR; Maki RG; Keohan ML
    Cancer; 2012 Jul; 118(13):3330-6. PubMed ID: 22045619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomas and malignant phyllodes tumours of the breast--a retrospective study.
    Confavreux C; Lurkin A; Mitton N; Blondet R; Saba C; Ranchère D; Sunyach MP; Thiesse P; Biron P; Blay JY; Ray-Coquard I
    Eur J Cancer; 2006 Nov; 42(16):2715-21. PubMed ID: 17023158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
    Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
    Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): a Gynecologic Oncology Group Study.
    Sabbatini P; Sill MW; O'Malley D; Adler L; Secord AA;
    Gynecol Oncol; 2008 Dec; 111(3):455-60. PubMed ID: 18829087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study.
    Curtin JP; Blessing JA; Soper JT; DeGeest K
    Gynecol Oncol; 2001 Nov; 83(2):268-70. PubMed ID: 11606082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.